🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neuraminidase inhibitors (NAI) are effective anti-influenza antiviral treat...
Status
Terminated
Location
Hospices civils de Lyon
Start Date
2009-01
Trial ID
NCT00830323
Treatments Being Tested
In order to prevent the high mortality due to an hypothetic pandemic caused...
Status
Terminated
Location
Centre Investigateur 155
Start Date
2008-12
Trial ID
NCT00799760
Treatments Being Tested
In response to the European regulatory authorities, GSK is conducting a pos...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01156701
Treatments Being Tested
This trial will use a previously validated platform, to quantitatively asse...
Status
Recruiting
Location
Universidade Federal de Minas Gerais
Start Date
2023-02-22
Trial ID
NCT05648448
Zanamivir is a potent and highly selective inhibitor of the influenza virus...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-28
Trial ID
NCT02377401
Treatments Being Tested
This randomized, open-label, multicenter phase 2 trial will assess the safe...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2010-12
Trial ID
NCT01052480
Treatments Being Tested
The purpose of this study is to determine whether zanamivir aqueous solutio...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11
Trial ID
NCT01014988
Treatments Being Tested
Zanamivir is a neuraminidase inhibitor that has demonstrated effectiveness ...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01462487
Treatments Being Tested
Influenza infection is an important public health priority, with seasonal o...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-11-21
Trial ID
NCT04494412
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of zanamivir g...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-15
Trial ID
NCT01231620
Treatments Being Tested